Although Beyaz side effects are similar to those of Yasmin and Yaz, and even though some lawsuits name all three birth control pills, Bayer's Annual Report 2013 does not mention Beyaz in its Legal Risks Section. The Annual Report discusses other Beyaz lawsuit risks, but not those alleging side effects from Beyaz birth control.

Beyaz, like Yasmin and Yaz, is oral birth control that contains drospirenone. Drospirenone has been linked to an increased risk of blood clots in women that use birth control. All three drugs have been named in lawsuits alleging Bayer, maker of Yasmin, Yaz, and Beyaz failed to adequately warn patients and medical professionals about the risk of blood clots linked to birth control. Beyaz is slightly different from Yasmin and Yaz in that it also contains folate.

Bayer's Annual Report 2013 (found online at annualreport2013.bayer.com) refers to Yasmin and Yaz litigation in its Legal Risks section. The Annual Report notes that as of February 10, 2014, the number of claimants in pending lawsuits concerning Yasmin and Yaz was around 4,600. The report also mentions Ocella and Gianvi, generic versions of Yasmin and Yaz. Claimants in those lawsuits allege they suffered serious personal injuries from use of the birth control pills. To read the entire article click here.